z-logo
Premium
Schizandrin reverses memory impairment in rats
Author(s) -
Egashira Nobuaki,
Kurauchi Kouji,
Iwasaki Katsunori,
Mishima Kenichi,
Orito Kensuke,
Oishi Ryozo,
Fujiwara Michihiro
Publication year - 2008
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.2258
Subject(s) - memory impairment , muscarinic acetylcholine receptor , oxotremorine , antagonist , agonist , cholinergic , pharmacology , endocrinology , scopolamine , medicine , muscarinic antagonist , chemistry , receptor , cognition , psychiatry
The present study investigated the effect of schizandrin, a component of the fruit of Schizandra chinesis Baill (Fructus Schizandrae), on memory impairment in rats. Scopolamine (0.5 mg/kg, i.p.), a non‐selective muscarinic receptor antagonist, markedly impaired spatial memory in an eight‐arm radial maze. A higher dose of scopolamine (3 mg/kg, i.p.) also impaired the passive avoidance response. Schizandrin (1 and 10 mg/kg, p.o.) significantly reversed the scopolamine‐induced impairment of spatial memory. Similarly, schizandrin (1 mg/kg, p.o.) significantly reversed the scopolamine‐induced impairment of the passive avoidance response. Moreover, in mice, schizandrin (1 and 10 mg/kg, p.o.) enhanced tremors induced by oxotremorine, a muscarinic M 1 receptor agonist. Taken together these findings suggest that schizandrin reverses scopolamine‐induced memory impairment, in part, by enhancing cholinergic function, and that schizandrin might be useful for treating memory deficits. Copyright © 2007 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom